Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells

Pharmacology

Volumn 80, Issue 2-3, 2007, Pages 134-143

  Alkhalaf, Moussa ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anticancer drugs; Apoptosis; Chemoprevention; p53; p70S6K; Phosphatidylinositol 3 kinase inhibitors; Phospho S6 ribosomal protein; Resveratrol; T47D breast cancer cells

Indexed keywords

LIPOCORTIN 5; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P53; RESVERATROL; TUMOR SUPPRESSOR PROTEIN; WORTMANNIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; GIEMSA STAIN; GROWTH INHIBITION; HUMAN; IMMUNOBLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOSPHORYLATION; POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTEIN BIOSYNTHESIS; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; STILBENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34547793672     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103253     Document Type: Article

References (48)

1. Langcake P, Pryce RJ: A new class of phytoalexins from grapevines. Experientia 1977;33:151-152.
2. Jeanet P, Bessis R, Gautheron B: The production of resveratrol (3,5,4′-trihydroxystilbene) by grape berries in different stages. Am J Enol Viticul 1991;42:41-46.
3. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
4. Fremont L: Biological effects of resveratrol. Life Sci 2000;66:663-673.
5. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ: Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 2001;8:3-17.
6. Pezzuto JM: Resveratrol: a whiff that induces a biologically specific tsunami. Cancer Biol Ther 2004;3:889-890.
7. Juan ME, Vinardell MP, Planas JM: The daily oral administration of high doses of transresveratrol to rats for 28 days is not harmful. J Nutr 2002;132:257-260.
8. Horn TL, Cwik MJ, Morrissey RL, Kapetanovic I, Crowell JA, Booth TD, McCormick DL: Oncogenicity evaluation of resveratrol in p53((+/-)) (p53 knockout) mice. Food Chem Toxicol 2007;45:55-63.
9. Soleas GJ, Diamandis EP, Goldberg DM: The world of resveratrol. Adv Exp Med Biol 2001;492:159-182.
10. Das DK, Sato M, Ray PS, Maulik G, Engelman RM, Bertelli AA, Bertelli A: Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res 1999;25:115-120.
11. Tessitore L, Davit A, Sarotto I, Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 2000;21:1619-1622.
12. Banerjee S, Bueso-Ramos C, Aggarwal BB: Suppression of 7,12-dimethylbenz(a)anthra cene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002;62:4945-4954.
13. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H: Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001;7:1466-1473.
14. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002;8:893-903.
15. Shih A, Davis FB, Lin HY, Davis PJ: Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 2002;87:1223-1232.
16. El-Mowafy AM, Alkhalaf M: Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 2003;24:869-873.
17. Narayanan BA, Narayanan NK, Re GG, Nixon DW: Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 2003;104:204-412.
18. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM: Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: Relevance in cell proliferation. Int J Cancer 2004;109:167-173.
19. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Salguero PM: Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 2005;115:74-84.
20. Alkhalaf M, Jaffal S: Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: novel cellular mechanisms involving ERKs/p53 cascade. Free Radic Biol Med 2006;41:318-325.
21. Lane DP: Cancer. p53, guardian of the genome. Nature 1992;358:15-16.
22. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR: The p53 network. J Biol Chem 1998;273:1-4.
23. Fogal V, Hsieh JK, Royer C, Zhong S, Lu X: Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315. EMBO J 2005;24:2768-2782.
24. Shieh SY, Ikeda M, Taya Y, Prives C: DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997;91:325-334.
25. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y: Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 1999;18:3205-3212.
26. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM: Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1999;59:2596-2601.
27. She QB, Bode AM, Ma WY, Chen NY, Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001;61:1604-1610.
28. Huang C, Ma WY, Goranson A, Dong Z: Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999;20:237-242.
29. Toillon RA, Chopin V, Jouy N, Fauquette W, Boilly B, Le Bourhis X: Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells. Breast Cancer Res Treat 2002;71:269-280.
30. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998;273:33533-33539.
31. Hemstrom TH, Sandstrom M, Zhivotovsky B: Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells. Int J Cancer 2006;119:1028-1038.
32. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
33. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
34. Tilleray V, Constantinou C, Clemens MJ: Regulation of protein synthesis by inducible wild-type p53 in human lung carcinoma cells. FEBS Lett 2006;580:1766-1770.
35. Pullen N, Thomas G: The modular phosphorylation and activation of p70s6k. FEBS Lett 1997;410:78-82.
36. Nicholson KM, Anderson NG: The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 2002;14:381-395.
37. Osaki M, Oshimura M, Ito H: PI3K-Akt: Its functions and alterations in human cancer. Apoptosis 2004;9:667-676.
38. Nifli AP, Kampa M, Alexaki VI, Notas G, Castanas E: Polyphenol interaction with the T47D human breast cancer cell line. J Dairy Res 2005;72:44-50.
39. Vyas S, Asmerom Y, De Leon DD: Resveratrol regulates insulin-like growth factor-II in breast cancer cells. Endocrinology 2005;146:4224-4233.
40. Zhang S, Cao HJ, Davis FB, Tang HY, Davis PJ, Lin HY: Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells. Br J Cancer 2004;91:178-185.
41. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, Park KY, Choi YH: Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep 2004;11:441-446.
42. Laux MT, Aregullin M, Berry JP, Flanders JA, Rodriguez E: Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol. J Altern Complement Med 2004;10:235-239.
43. Dufner A, Thomas G: Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 1999;253:100-109.
44. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM: Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 2002;62:772-777.
45. Li HL, Wang AB, Huang Y, Liu DP, Wei C, Williams GM, Zhang CN, Liu G, Liu YQ, Hao DL, Hui RT, Lin M, Liang CC: Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 2005;38:243-257.
46. Peterson RT, Schreiber SL: Translation control: connecting mitogens and the ribosome. Curr Biol 1998;8:R248-250.
47. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G: Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 1997;16:3693-3704.
48. Horton LE, Bushell M, Barth-Baus D, Tilleray VJ, Clemens MJ, Hensold JO: p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene 2002;21:5325-5334.